Par Pharm Company Profile
What is the competitive landscape for PAR PHARM
PAR PHARM has seventy-five approved drugs.
There is one US patent protecting PAR PHARM drugs. There are thirteen tentative approvals on PAR PHARM drugs.
Summary for Par Pharm
| US Patents: | 1 |
| Tradenames: | 36 |
| Ingredients: | 36 |
| NDAs: | 75 |
| Patent Litigation for Par Pharm: | See patent lawsuits for Par Pharm |
| PTAB Cases with Par Pharm as petitioner: | See PTAB cases with Par Pharm as petitioner |
Drugs and US Patents for Par Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Pharm | PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride; perphenazine | TABLET;ORAL | 070620-001 | Sep 11, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Par Pharm | PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride; perphenazine | TABLET;ORAL | 070565-001 | Sep 11, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Par Pharm | HYDROFLUMETHIAZIDE | hydroflumethiazide | TABLET;ORAL | 088850-001 | May 31, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Par Pharm | IBUPROFEN | ibuprofen | TABLET;ORAL | 070328-001 | Aug 6, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Par Pharm | CLONIDINE HYDROCHLORIDE | clonidine hydrochloride | TABLET;ORAL | 070460-001 | Jul 8, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Par Pharm | TRICHLORMETHIAZIDE | trichlormethiazide | TABLET;ORAL | 087005-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Par Pharm Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2006240490 | ⤷ Start Trial |
| South Korea | 20080000660 | ⤷ Start Trial |
| Mexico | 2007013118 | ⤷ Start Trial |
| Japan | 5378788 | ⤷ Start Trial |
| China | 101163679 | ⤷ Start Trial |
| European Patent Office | 1948613 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Par Pharm Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1781277 | PA2024501 | Lithuania | ⤷ Start Trial | PRODUCT NAME: IBUPROFENO IR PARACETAMOLIO DERINYS; REGISTRATION NO/DATE: LT/1/23/5212/001-002 20230726 |
| 0454511 | SPC/GB99/008 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-((2'-(TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-2-IMIDAZOLIN-5-ONE)(GENERIC NAME IRBESARTAN) OPTIONALLY IN THE FORM OF ONE OF ITS SALTS AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/98/086/001 19981015; UK EU/1/98/086/002 19981015; UK EU/1/98/086/003 19981015; UK EU/1/98/086/004 19981015; UK EU/1/98/086/005 19981015; UK EU/1/98/086/006 19981015 |
| 0836511 | CA 2006 00019 | Denmark | ⤷ Start Trial | PRODUCT NAME: FENTANYL HYDROCHLORID |
| 3185856 | LUC00356 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: COMBINATION OF DOXYLAMINE, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PYRIDOXINE, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; AUTHORISATION NUMBER AND DATE: 2024030081, 20240220 |
| 1769785 | C300522 | Netherlands | ⤷ Start Trial | PRODUCT NAME: FENTANYL EN DOSERINGSAPPLICATOR; REG. NO/DATE: EU/2/11/127/001 20111006 |
| 1769785 | C300521 | Netherlands | ⤷ Start Trial | PRODUCT NAME: FENTANYL; REG NO/DATE: EU/2/11/127/001 20111006 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
